Lahore: Citi Pharma Limited has scheduled a Board of Directors meeting for October 29, 2024, to discuss and potentially declare entitlements based on the quarterly accounts ending September 30, 2024. This crucial meeting, set to convene at the company’s headquarters in Lahore, will be instrumental in reviewing the financial outcomes and strategizing future directives.

The company, according to a notice sent to the General Manager of the Pakistan Stock Exchange, has also initiated a closed period from October 22 to October 29, 2024, aligning with PSX regulations 5.6.1(d). During this time, directors, the CEO, and other executives are restricted from trading shares of Citi Pharma. According to information available from the Pakistan Stock Exchange (PSX), this measure ensures transparency and fairness leading up to the disclosure of financial results.

Stakeholders, including TRE Certificate Holders of the PSX, have been advised of the closed period, ensuring compliance with regulatory expectations and maintaining market integrity during the lead-up to the financial announcements.